Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab.
Suematsu H, Kano K, Yamada T, Hashimoto I, Watanabe H, Takahashi K, Watanabe M, Hayashi K, Kaneta Y, Furuta M, Inokuchi Y, Machida N, Aoyama T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T.
Suematsu H, et al. Among authors: machida n.
Anticancer Res. 2022 Mar;42(3):1535-1540. doi: 10.21873/anticanres.15626.
Anticancer Res. 2022.
PMID: 35220249